Home Virion Therapeutics

Virion Therapeutics

In operation
Series A
Cancer Drug Developer
Basic
Enterprise Profile

Basic Information

Virion Therapeutics is a science-driven company developing innovative immune-based treatments for virus-associated cancers. Their vaccines, ChiVax and ChiVax-gD, represent novel and efficient platforms capable of inducing potent and sustained T cell-mediated immune responses against transformed or infected cells, enabling us to target prevalent diseases with unmet medical needs.
Virion Therapeutics,LLC
Delaware,United States of America
less than 15 people
January 01, 2018
info@viriontx.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Gene Technology Biotechnology
Concept
Tumor
Application Scenarios
Traditional Vaccines (Biological Products for Prevention)